Page 4 - Narcolepsy Type News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Centessa Pharmaceuticals (NASDAQ:CNTA – Get Rating) and Dermata Therapeutics (NASDAQ:DRMA – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, valuation, institutional ownership, risk and dividends. Earnings & Valuation This table compares Centessa Pharmaceuticals and […]

Patients treated with Mazindol ER in the randomized Phase 2 trial showed continued improvement after rolling over into the open label extension (OLE) studyPatients treated with placebo in the randomized

Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) and Centessa Pharmaceuticals (NASDAQ:CNTA – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, risk and profitability. Institutional & Insider Ownership 55.9% of Merrimack Pharmaceuticals shares […]

Investegate announcements from Centessa Pharmaceuticals plc, Centessa Pharmaceuticals Reports Fourth Quarter and 2021 Financial Results and Provides Business Update

- Company strengthens strategic focus on rare disease and immuno-oncology assets and details expected upcoming clinical milestones - - SerpinPC registration studies planned to begin in 2H 2022 following